Waqas T Qureshi1, Zhu-Ming Zhang2, Patricia P Chang3, Wayne D Rosamond4, Dalane W Kitzman1, Lynne E Wagenknecht5, Elsayed Z Soliman6. 1. Department of Internal Medicine, Section on Cardiology, Wake Forest School of Medicine, Winston Salem, North Carolina. 2. Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Division of Cardiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 4. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 5. Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina. 6. Department of Internal Medicine, Section on Cardiology, Wake Forest School of Medicine, Winston Salem, North Carolina; Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina. Electronic address: esoliman@wakehealth.edu.
Abstract
BACKGROUND: Although silent myocardial infarction (SMI) accounts for about one-half of the total number of myocardial infarctions (MIs), the risk of heart failure (HF) among patients with SMI is not well established. OBJECTIVES: The purpose of this study was to examine the association of SMI and clinically manifested myocardial infarction (CMI) with HF, as compared with patients with no MI. METHODS: This analysis included 9,243 participants from the ARIC (Atherosclerosis Risk In Communities) study who were free of cardiovascular disease at baseline (ARIC visit 1: 1987 to 1989). SMI was defined as electrocardiographic evidence of MI without CMI after the baseline until ARIC visit 4 (1996 to 1998). HF events were ascertained starting from ARIC visit 4 until 2010 in individuals free of HF before that visit. RESULTS: Between ARIC visits 1 and 4, 305 SMIs and 331 CMIs occurred. After ARIC visit 4 and during a median follow-up of 13.0 years, 976 HF events occurred. The incidence rate of HF was higher in both CMI and SMI participants than in those without MI (incidence rates per 1,000 person-years were 30.4, 16.2, and 7.8, respectively; p < 0.001). In a model adjusted for demographics and HF risk factors, both SMI (hazard ratio [HR]: 1.35; 95% confidence interval [CI]: 1.02 to 1.78) and CMI (HR: 2.85; 95% CI: 2.31 to 3.51) were associated with increased risk of HF compared with no MI. These associations were consistent in subgroups of participants stratified by several HF risk predictors. However, the risk of HF associated with SMI was stronger in those younger than the median age (53 years) (HR: 1.66; 95% CI: 1.00 to 2.75 vs. HR: 1.19; 95% CI: 0.85 to 1.66, respectively; overall interaction p by MI type <0.001). CONCLUSIONS: SMI is associated with an increased risk of HF. Future research is needed to examine the cost effectiveness of screening for SMI as part of HF risk assessment, and to identify preventive therapies to improve the risk of HF among patients with SMI.
BACKGROUND: Although silent myocardial infarction (SMI) accounts for about one-half of the total number of myocardial infarctions (MIs), the risk of heart failure (HF) among patients with SMI is not well established. OBJECTIVES: The purpose of this study was to examine the association of SMI and clinically manifested myocardial infarction (CMI) with HF, as compared with patients with no MI. METHODS: This analysis included 9,243 participants from the ARIC (Atherosclerosis Risk In Communities) study who were free of cardiovascular disease at baseline (ARIC visit 1: 1987 to 1989). SMI was defined as electrocardiographic evidence of MI without CMI after the baseline until ARIC visit 4 (1996 to 1998). HF events were ascertained starting from ARIC visit 4 until 2010 in individuals free of HF before that visit. RESULTS: Between ARIC visits 1 and 4, 305 SMIs and 331 CMIs occurred. After ARIC visit 4 and during a median follow-up of 13.0 years, 976 HF events occurred. The incidence rate of HF was higher in both CMI and SMI participants than in those without MI (incidence rates per 1,000 person-years were 30.4, 16.2, and 7.8, respectively; p < 0.001). In a model adjusted for demographics and HF risk factors, both SMI (hazard ratio [HR]: 1.35; 95% confidence interval [CI]: 1.02 to 1.78) and CMI (HR: 2.85; 95% CI: 2.31 to 3.51) were associated with increased risk of HF compared with no MI. These associations were consistent in subgroups of participants stratified by several HF risk predictors. However, the risk of HF associated with SMI was stronger in those younger than the median age (53 years) (HR: 1.66; 95% CI: 1.00 to 2.75 vs. HR: 1.19; 95% CI: 0.85 to 1.66, respectively; overall interaction p by MI type <0.001). CONCLUSIONS: SMI is associated with an increased risk of HF. Future research is needed to examine the cost effectiveness of screening for SMI as part of HF risk assessment, and to identify preventive therapies to improve the risk of HF among patients with SMI.
Authors: J Nadelmann; W H Frishman; W L Ooi; D Tepper; S Greenberg; H Guzik; E J Lazar; M Heiman; M Aronson Journal: Am J Cardiol Date: 1990-09-01 Impact factor: 2.778
Authors: Kathy Hebert; Barbara Lopez; Andre Dias; Dylan L Steen; Rosario A Colombo; Emiliana Franco; Sholom Neistein; Lee M Arcement Journal: Congest Heart Fail Date: 2010 Jan-Feb
Authors: Christoffer Polcwiartek; Kristian Kragholm; Steen M Hansen; Brett D Atwater; Daniel J Friedman; Carlo A Barcella; Claus Graff; Jonas B Nielsen; Adrian Pietersen; Jimmi Nielsen; Peter Søgaard; Christian Torp-Pedersen; Svend E Jensen Journal: Schizophr Bull Date: 2020-02-26 Impact factor: 9.306
Authors: Alexander E Merkler; Traci M Bartz; Hooman Kamel; Elsayed Z Soliman; Virginia Howard; Bruce M Psaty; Peter M Okin; Monika M Safford; Mitchell S V Elkind; W T Longstreth Journal: Neurology Date: 2021-05-24 Impact factor: 11.800
Authors: Panagiotis Antiochos; Yin Ge; Kevin Steel; Scott Bingham; Shuaib Abdullah; J Ronald Mikolich; Andrew E Arai; W Patricia Bandettini; Amit R Patel; Afshin Farzaneh-Far; John F Heitner; Chetan Shenoy; Steve W Leung; Jorge A Gonzalez; Dipan J Shah; Subha V Raman; Victor A Ferrari; Jeanette Schulz-Menger; Matthias Stuber; Orlando P Simonetti; Raymond Y Kwong Journal: J Am Coll Cardiol Date: 2020-08-25 Impact factor: 24.094
Authors: Merry L Lindsey; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Nikolaos G Frangogiannis; Ganesh V Halade; Caitlin C O'Meara; Francis G Spinale; Zamaneh Kassiri; Jonathan A Kirk; Petra Kleinbongard; Crystal M Ripplinger; Keith R Brunt Journal: Am J Physiol Heart Circ Physiol Date: 2021-06-11 Impact factor: 5.125
Authors: James D Pollard; Kazi T Haq; Katherine J Lutz; Nichole M Rogovoy; Kevin A Paternostro; Elsayed Z Soliman; Joseph Maher; Joo A C Lima; Solomon K Musani; Larisa G Tereshchenko Journal: Eur Heart J Digit Health Date: 2021-01-20